0Suppliers
2Customers
3Debt Items
9Related Chains

Aldeyra Therapeutics, Inc. Suppliers

No suppliers on recordAldeyra Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Aldeyra Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ABBV AbbVie Inc. 90% Outside of the United States, the Company would be eligible to receive tiered royalties on net sales of reproxalap.
ABBV AbbVie Inc. 90% Reciprocal relationship from ABBV graph: Reciprocal relationship from ALDX graph: Outside of the United States, the Company would be eligible to receive tiered royalties on net sales of reproxalap.

Aldeyra Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALDX-DEBT-7669 Warrants outstanding: 211528 90% xbrl warrant detail from xbrl 2018-12-31.
ALDX-DEBT-7670 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.
ALDX-DEBT Debt stack $15.5M 90% Market cache reports total debt of $15.5M.

Aldeyra Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Aldeyra Therapeutics, Inc..

Aldeyra Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ALDX-OWNER-KNOLL-CAPITAL-MANAGEMENT-LLC Knoll Capital Management, LLC 90% 13F overlay lists Knoll Capital Management, LLC as top holder; 125 tracked holders.

Aldeyra Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CTMX CytomX Therapeutics, Inc. 100.00 2
JNJ Johnson & Johnson 100.00 2
ABBVIE ABBVIE 60.75 1 ['receiving']
ABBV AbbVie Inc. 60.75 1 ['customer']
IRWD Ironwood Pharmaceuticals, Inc. 50.00 2
XLO Xilio Therapeutics, Inc. 50.00 2
IRON Disc Medicine, Inc. 37.71 2
SION Sionna Therapeutics, Inc. 36.09 2
ARGX argenx SE 28.51 2